No Data
OrbusNeich to Re-evaluate Share Issuance Strategy
OrbusNeich Seeks Shareholder Approval for New Mandates
Orbusneich (06929): It is recommended to revoke the existing general authorization and grant a new general authorization.
According to the latest revision of the listing rules regarding treasury shares, orbusneich (06929) announced that from June 2024...
[Special Guest V] Guo Jiayao: The market anticipates more stimulating policies introduced in the mainland to boost consumer and real estate markets.
Jingu Financial News | U.S. stocks performed positively on Thursday, with strong U.S. data and China's large-scale stimulus measures, providing a bullish atmosphere for the market. All three major indices recorded gains at the close. The U.S. dollar fluctuated downwards, with the yield on the U.S. ten-year bond maintaining at 3.79 basis points. Gold prices hit a new high again, while oil prices remained soft. Hong Kong H shares generally rose, and it is expected that the market will open high in the morning. Mainland Chinese stocks continued to perform well, with the Shanghai Composite Index opening low and closing high, rising by 3.6% to over 3,000 points. The trading volume in the Shanghai and Shenzhen markets exceeded one trillion yuan once again. Hong Kong stocks have been performing exceptionally well recently, with the index approaching the 20,000-point level, and the market turnover increasing rapidly to
Health Industry Medical (6929.HK): Its Dutch high-capacity logistics center is officially operational.
9月25日，Global Gathering Medical (6929.HK), a leading global manufacturer of medical devices specializing in percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) interventional instruments, officially launched its ultra-modern logistics center located in the Netherlands. The group's investment in building the new warehouse aims to meet the increasing demand in production and fulfill the growing need for logistics and storage capacity. This move not only demonstrates the group's commitment and investment in customer service, quality compliance, digitization, and sustainable development but also believed to significantly drive its production base in Hoofddorp, Netherlands.
ORBUSNEICH: INTERIM REPORT 2024
No Data
No Data